8-K: Procter & Gamble Reports Q3 FY2026 Results

The Procter & Gamble Company announced its third quarter fiscal year 2026 results, showing sequential improvement in organic sales and core earnings per share.

Summary

• The Procter & Gamble Company reported sequential and broad-based improvement in its third quarter of fiscal year 2026, despite a challenging macro environment.
• Organic sales grew by 3% year-over-year, driven by a 2% increase in volume and a 1% increase in pricing.
• All 10 product categories and 7 out of 7 regions achieved organic sales growth for the quarter.
• Global aggregate value share remained in line with the prior year, with 26 of the top 50 category/country combinations holding or growing share.
• Core earnings per share (EPS) were $1.59, a 3% increase compared to the prior year. On a currency-neutral basis, core EPS was $1.54, in line with the prior year.
• Adjusted Free Cash Flow Productivity was 82% for the quarter.
• The company maintained its fiscal year 2026 guidance for organic sales growth of 0% to 4% and net sales growth of 1% to 5%.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report, indicating resilience and sequential improvement in a challenging environment, with maintained guidance, but tempered by flat currency-neutral EPS and some share declines in specific categories.

Positives

• Organic sales grew 3% year-over-year, with broad-based improvement across categories and regions.
• 10 out of 10 product categories and 7 out of 7 regions grew organic sales.
• Core EPS increased by 3% to $1.59, demonstrating improved profitability.
• Global aggregate value share was maintained, with 26 of the top 50 category/country combinations holding or growing share.
• Adjusted Free Cash Flow Productivity was strong at 82%.

Negatives

• On a currency-neutral basis, core EPS was flat compared to the prior year.
• Global Skin Care value share decreased by 0.8 points and Global Hair Care value share decreased by 0.5 points.
• Global Grooming value share decreased by 0.4 points.
• Global Fabric Care value share decreased by 0.2 points.
• Global Baby Care value share increased by 0.2 points, but Global Feminine Care share decreased by 0.2 points and Global Family Care share decreased by 0.8 points.

Risks

• Potential for significant deceleration of market growth rates.
• Risk of significant currency weakness.
• Possibility of significant commodity cost increases.
• Uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls.
• Potential for disruptions in credit markets or to banking partners.
• Risks associated with maintaining key manufacturing and supply arrangements and managing business disruptions due to factors outside of control, such as natural disasters, conflicts or acts of war.
• Ability to manage cost fluctuations and pressures, including prices of commodities, raw materials, labor, transportation, energy, pension, and healthcare.
• Challenges in competing with local and global competitors in new and existing sales channels.

Future Outlook

The company maintained its fiscal year 2026 guidance, projecting organic sales growth of 0% to 4%, net sales growth of 1% to 5%, core EPS growth of 0% to 4%, and all-in EPS growth of 1% to 6%. Currency-neutral core EPS growth is expected to be between -1% and +3%. Adjusted free cash flow productivity is projected at 85% to 90%. Capital spending is estimated at 4% to 5% of sales, with approximately $10 billion for dividends and $5 billion for direct share repurchases.

Management Comments

• Third quarter showed sequential and broad-based improvement despite an increasingly challenging macro environment.
• Organic sales grew 3% vs prior year. Volume +2%, Pricing +1%.
• 10 of 10 product categories and 7 of 7 regions grew organic sales for the quarter.
• Global aggregate value share was in line with the prior year, with 26 of our top 50 category/country combinations holding or growing share for the quarter.
• Core earnings per share were $1.59, +3% vs the prior year. On a currency-neutral basis, core EPS was $1.54, in line with the prior year.

Industry Context

StockSavvy.ai notes that Procter & Gamble's performance in Q3 FY2026, with broad-based organic sales growth across most categories and regions, reflects resilience in the consumer staples sector amidst a challenging macro environment. The company's ability to maintain value share in key segments indicates effective brand management and competitive positioning.

Comparison to Industry Standards

• The 3% organic sales growth reported by Procter & Gamble for Q3 FY2026 is generally considered solid within the consumer staples industry, especially given the challenging macro environment. Competitors like Unilever and Kimberly-Clark have also reported varying degrees of organic growth, with some facing greater pressure on volumes due to inflation.
• P&G's ability to grow core EPS by 3% while maintaining value share suggests effective cost management and pricing strategies, which are critical benchmarks for success in this sector.
• The 82% Adjusted Free Cash Flow Productivity is a strong indicator of operational efficiency, often outperforming many peers in the industry who may struggle to convert earnings into cash due to higher capital expenditures or working capital needs.

Stakeholder Impact

• Shareholders: Continued dividend payments and share repurchases are supported by strong cash flow generation, providing potential returns.
• Employees: The focus on an agile and accountable organization may lead to changes in work structures and performance expectations.
• Customers: The emphasis on 'winning with consumers' and 'portfolio performance drives brand choice' suggests continued efforts to meet consumer needs and preferences.
• Suppliers: The mention of commodity cost pressures and supply chain management indicates ongoing importance of supplier relationships and potential for cost negotiations.

Next Steps

• Continue to execute integrated growth strategy.
• Focus on winning with consumers through portfolio performance and brand choice.
• Drive productivity to fuel investments.
• Empower an agile and accountable organization.
• Continue to monitor and manage potential headwinds not included in guidance.

Key Dates

Recommendation

The filing shows stable performance with sequential improvements and maintained guidance, but the lack of significant upside surprises and the presence of some category share declines suggest a 'hold' recommendation. The company is navigating a challenging macro environment effectively, but substantial catalysts for significant price appreciation are not evident in this report.

Keywords

Procter & Gamble, P&G, 8-K, SEC Filing, Q3 FY2026, Earnings, Organic Sales, Core EPS